Literature DB >> 24374072

Retention studies of recoiling daughter nuclides of 225Ac in polymer vesicles.

G Wang1, R M de Kruijff1, A Rol1, L Thijssen1, E Mendes2, A Morgenstern3, F Bruchertseifer3, M C A Stuart4, H T Wolterbeek1, A G Denkova5.   

Abstract

Alpha radionuclide therapy is steadily gaining importance and a large number of pre-clinical and clinical studies have been carried out. However, due to the recoil effects the daughter recoil atoms, most of which are alpha emitters as well, receive energies that are much higher than the energies of chemical bonds resulting in decoupling of the radionuclide from common targeting agents. Here, we demonstrate that polymer vesicles (i.e. polymersomes) can retain recoiling daughter nuclei based on an experimental study examining the retention of (221)Fr and (213)Bi when encapsulating (225)Ac.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alpha radionuclide therapy; Polymersomes; Recoil retention

Mesh:

Substances:

Year:  2013        PMID: 24374072     DOI: 10.1016/j.apradiso.2013.12.008

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  10 in total

1.  Radiolabeling of Theranostic Nanosystems.

Authors:  Sudeep Das; Surachet Imlimthan; Anu J Airaksinen; Mirkka Sarparanta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Targeted and Nontargeted α-Particle Therapies.

Authors:  Michael R McDevitt; George Sgouros; Stavroula Sofou
Journal:  Annu Rev Biomed Eng       Date:  2018-01-18       Impact factor: 9.590

Review 3.  A Critical Review of Alpha Radionuclide Therapy-How to Deal with Recoiling Daughters?

Authors:  Robin M de Kruijff; Hubert T Wolterbeek; Antonia G Denkova
Journal:  Pharmaceuticals (Basel)       Date:  2015-06-10

Review 4.  A random walk approach to estimate the confinement of α-particle emitters in nanoparticles for targeted radionuclide therapy.

Authors:  Uwe Holzwarth; Isaac Ojea Jimenez; Luigi Calzolai
Journal:  EJNMMI Radiopharm Chem       Date:  2018-05-30

5.  Fluorescent nuclear track detectors for alpha radiation microdosimetry.

Authors:  J J M Kouwenberg; H T Wolterbeek; A G Denkova; A J J Bos
Journal:  Radiat Oncol       Date:  2018-06-07       Impact factor: 3.481

Review 6.  Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure.

Authors:  Sture Lindegren; Per Albertsson; Tom Bäck; Holger Jensen; Stig Palm; Emma Aneheim
Journal:  Cancer Biother Radiopharm       Date:  2020-02-20       Impact factor: 3.099

Review 7.  Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.

Authors:  Joshua Loya; Charlie Zhang; Emily Cox; Achal S Achrol; Santosh Kesari
Journal:  CNS Oncol       Date:  2019-11-21

8.  Uptake and subcellular distribution of radiolabeled polymersomes for radiotherapy.

Authors:  Stefan J Roobol; Thomas A Hartjes; Johan A Slotman; Robin M de Kruijff; Guzman Torrelo; Tsion E Abraham; Frank Bruchertseifer; Alfred Morgenstern; Roland Kanaar; Dik C van Gent; Adriaan B Houtsmuller; Antonia G Denkova; Martin E van Royen; Jeroen Essers
Journal:  Nanotheranostics       Date:  2020-01-01

9.  225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins.

Authors:  Tania Hernández-Jiménez; Guillermina Ferro-Flores; Enrique Morales-Ávila; Keila Isaac-Olivé; Blanca Ocampo-García; Liliana Aranda-Lara; Clara Santos-Cuevas; Myrna Luna-Gutiérrez; Laura De Nardo; Antonio Rosato; Laura Meléndez-Alafort
Journal:  Molecules       Date:  2022-03-27       Impact factor: 4.411

10.  Sub-10 nm Radiolabeled Barium Sulfate Nanoparticles as Carriers for Theranostic Applications and Targeted Alpha Therapy.

Authors:  Falco Reissig; Kristof Zarschler; René Hübner; Hans-Jürgen Pietzsch; Klaus Kopka; Constantin Mamat
Journal:  ChemistryOpen       Date:  2020-06-08       Impact factor: 2.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.